Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
2 min synopsisUK scopeSources checked 27 Aug 2026Clinical review pending
!
Assess failure before routine replacement
A missed pill outside its product window, injection beyond the accepted interval, expired implant, interacting enzyme inducer or pregnancy symptoms after recent intercourse may represent contraceptive failure.
Action: Establish exact product and dates, offer emergency contraception when indicated, restart or bridge according to method-specific rules and arrange pregnancy testing 21 days after the latest risk.
Synopsis
Select and use progestogen-only pills, the etonogestrel implant and injectable contraception safely, with exact timing, bleeding, interaction, bone-health and fertility-return counselling.
Progestogen-only methods avoid oestrogen and are suitable for many people who cannot use CHC, but current breast cancer and some serious liver or vascular conditions still alter eligibility.
Know the pill formulation: traditional norethisterone or levonorgestrel POP has a three-hour late window, desogestrel a 12-hour window and drospirenone a 24-hour window with different missed-pill rules.
The etonogestrel implant is over 99% effective and, following the 2026 UK licence extension, provides contraception for five years; check the actual insertion and replacement date.
Key red flags
Severe abdominal pain, collapse or bleeding with a positive pregnancy test needs urgent ectopic-pregnancy assessment even though absolute pregnancy risk on these methods is low.
Investigation priorities
01
Pregnancy-risk assessmentFirst step
Identify emergency contraception, safe initiation and repeat-testing needs after missed or late use.
Management branches
Method selectionMatch duration and reversibility
A patient wants an oestrogen-free hormonal method.
Compare daily pill timing, a five-year removable implant and a 13-week injection that cannot be withdrawn, including typical effectiveness and privacy.
Apply UKMEC and assess enzyme inducers, bleeding priorities, future pregnancy timing, weight and bone-health factors relevant to DMPA.
Key medicines
Desogestrel 75 microgram progestogen-only pillTake one tablet orally at the same time every day without a pill-free interval; a dose more than 12 hours late is missed and requires the product-specific missed-pill pathway.
Drospirenone 4 mg progestogen-only pillTake one active tablet orally daily for 24 days followed by four inactive tablets in each 28-day pack; use its 24-hour missed-pill window and formulation-specific instructions.
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.